Penny Stocks Icon

Penny Stocks

Penny stocks trade at less than $5 per share. They are highly volatile and incredibly risky investments that can burn new and seasoned investors alike; they often serve as the playground for scam artists and market manipulators. However, while penny stocks can be halved in the blink of an eye, they can also double much more quickly than large-cap stocks. Investors interested in penny stocks should be aware of the risks and do their due diligence before making an investment. Read on to find out how to profit without getting scammed.

Recent Penny Stocks Articles

Why Is BurgerFi International (BFI) Stock Up 71% Today?

BurgerFi International stock is up on Friday as investors in BFI react to it reaching a settlement agreement with Lion Point Capital, LP.

Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?

Windtree Therapeutics stock is up on Friday with heavy trading of WINT shares following an update on its clinical trials.

Ticker Mix-Up? The Container Store (TCS) Stock Soars Despite No Clear News.

TCS stock jumped more than 80% Thursday for seemingly no reason. Are investors mixing up The Container Store with Tata Consultancy Services?

Why Is Predictive Oncology (POAI) Stock Up 70% Today?

Predictive Oncology’s AI-driven platform demonstrated predictive utility in oncology, thereby providing credibility to POAI stock.

TWOU Stock Alert: 2U Plunges on Ch. 11 Bankruptcy Filing

TWOU stock is plunging tremendously after the education company announced that it had declared bankruptcy today.

Why Is 2U (TWOU) Stock Down 71% Today?

2U stock is falling hard on Thursday as TWOU investors learn of the online education company filing for Chapter 11 bankruptcy.

Why Is Tivic Health Systems (TIVC) Stock Up 44% Today?

Tivic Health Systems stock is up on Thursday with heavy trading of TIVC after the company announced new patents in the U.S. and Europe.

Why Is Psyence Biomedical (PBM) Stock Up 163% Today?

Psyence Biomedical stock is up on Thursday with heavy trading of PBM shares after announcing its successful export to Australia.

Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?

Little-known firm Sangamo Therapeutics is surging today, with SGMO stock up more than 40% on promising late-stage trial results.

ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split

Allarity Therapeutics stock is up on Wednesday as the company pushes ALLR investors to vote in favor of a reverse stock split.

Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?

Pieris Pharmaceuticals stock is up on Wednesday as PIRS investors learn of the company preparing for a merger with Palvella Therapeutics.

Why Is Hoth Therapeutics (HOTH) Stock Moving Today?

Hoth Therapeutics stock is slipping on Wednesday even as investors in HOTH learn of a new partnership to assist its Alzheimer's treatment.

Why Is Conn’s (CONN) Stock Down 36% Today?

Conn’s stock is falling on Wednesday as CONN investors react to reports of potential store closures and a bankruptcy filing.

Why Is Azitra (AZTR) Stock Down 75% Today?

Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update.

Why Is Nuzee (NUZE) Stock Up 133% Today?

Nuzee stock is up on Wednesday with heavy trading of NUZE shares despite a lack of news from the coffee machine company.

Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today?

Dermata Therapeutics stock is up on Wednesday with heavy trading of the company's shares despite a lack of news this morning.

What Is Going on With Regencell Bioscience (RGC) Stock Today?

Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.

Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today?

While Salarius Pharmaceuticals encountered a hiccup in its genomics research, the possibility of new funding may have lifted SLRX stock.

Why Is Azitra (AZTR) Stock Up 315% Today?

Azitra stock is up on Tuesday alongside heavy trading of AZTR shares after it provided investors with an update on new patents.